Lilly reports positive interim results from Heart-2 trial of VERVE-102
The study involved 35 participants with heterozygous familial hypercholesterolaemia or premature coronary artery disease.
26 May 2026
26 May 2026
The study involved 35 participants with heterozygous familial hypercholesterolaemia or premature coronary artery disease.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.